Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Nat'l Exam for Physicians to Be Made More Accessible to the Handicapped
May 27, 2002
- Terumo: Sales Up 6.3% to \187,082 Mil.
May 27, 2002
- Wholesalers to Assist Makers in Immediate PMS
May 27, 2002
- General Risk Managers Appointed at All Nat'l Univ. Hospitals
May 27, 2002
- Olympus: New Digital Microscope "MIC-D"
May 27, 2002
- Drug Sales Up 3.5% in FY2001: CR&C
May 27, 2002
- GL on Subarachnoidal Hemorrhage Compiled
May 27, 2002
- AstraZeneca PLC: 1st Qtr Sales Up 13% to US$4,421 Mil.
May 27, 2002
- Otsuka Pharma Factory Sues Shionogi Claiming Infringement of Design Right
May 27, 2002
- Registration for J-WIND Increases Sharply
May 27, 2002
- Acarbose Prevents Type 2 Diabetes: STOP-NIDDM Study
May 27, 2002
- EPS Forms Alliance with VirtualeX for Subject Recruitment
May 27, 2002
- Mental Care Important for Atopic Dermatitis: ARC Seminar
May 27, 2002
- Novartis Opens Biomedical Research Center in US
May 27, 2002
- WEBSITE NEWS
May 27, 2002
- LWC to Undertake Survey on Lower Back Pain
May 27, 2002
- Novartis' Zometa to Be Approved for Bone Metastasis in the EU
May 27, 2002
- Teijin: Drug Sales, Operating Profits Up 6.7%, 7.0%
May 27, 2002
- Drug Terashima Joins AEON Welcia Stores
May 27, 2002
- Bayer AG: 1st Qtr Sales Down 6% to 7 Bil. Euro
May 27, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…